Magang, Jesarine C.

HRN: 26-54-34  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/16/2025
CEFTRIAXONE 1G (VIAL)
01/16/2025
01/23/2025
IV
2 Grams
Q24
Acute Glomerulonephritis
Waiting Final Action 
01/20/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
01/20/2025
01/26/2025
IV
1550 Mg
Q6H
Acute Glomerulonephritis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: